Ethylenediaminetetraacetic acid (EDTA)

Description:

Ethylenediaminetetraacetic acid (EDTA) is a compund used primarily as chelating agent. It has a particular affinity to attach ions that have a +2 charge, such as Lead (Pb++), Zinc (Zn++), Copper (Cu++), etc. It is used therapeutically to bind with heavy metals and other substances to allow such to be subsequently excreted by the body.

It can be used, in order of decreasing effectiveness, intravenously, via suppository and orally.

Physiologic Therapeutics:

• Pulls heavy metals from the body
• Dissolves LDL cholesterol plaques

Clinical Indications:

• Attention decficit disorder (ADD)
• Atherosclerosis
• Autism
• Bipolar disorder
• Benign prostatic hypertrophy (BPH)
• Chronic fatigue syndrome
• Depression
• Eczema
• Headache
• Fibromyalgia
• Fertility
• Hypercholesterolemia
• Hypertension
• Insomnia
• Memory Loss
• Migraine Headaches
• Parkinsons Disease
• Psoriasis
• Schizophrenia
• Uterine Fibroids
• Hypercalcemia
• Lead Poisoning

Dosage:

• Dosage:
  • Orally: 2 - 3 grams taken at bedtime
  • By suppository: 750 mg. at bedtime
  • IV: 40 - 70 mg. per kg.

Drug/Nutrient Interaction:

• EDTA may remove beneficial +2 ions such as magnesium, calcium and zinc which should be replaced via supplementation

Contraindications:

• Pregnancy
• Kidney failure
• Hypothyroidism

Adverse Reactions and Toxicity:

• Unpleasant skin odors
• Fatigue
• Nausea
• Occasional kidney damage (rare)

Copyright 1998 - 2008 by L. Vicky Crouse, ND and James S. Reiley, ND. All rights reserved (ISSN 1527-0661).